Randomized, Placebo-controlled, Single Blind, Trial to Determine the Safety and Efficacy of Ticagrelor for Maintaining Patency of Arterio-Venous Fistulae Created for Hemodialysis

Trial Profile

Randomized, Placebo-controlled, Single Blind, Trial to Determine the Safety and Efficacy of Ticagrelor for Maintaining Patency of Arterio-Venous Fistulae Created for Hemodialysis

Recruiting
Phase of Trial: Phase I/II

Latest Information Update: 04 Nov 2016

At a glance

  • Drugs Ticagrelor (Primary)
  • Indications Renal failure
  • Focus Adverse reactions
  • Most Recent Events

    • 24 Oct 2016 Planned End Date changed from 1 Mar 2017 to 1 Jun 2018.
    • 24 Oct 2016 Planned primary completion date changed from 1 Sep 2016 to 1 Dec 2017.
    • 14 Jan 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top